Sprott Inc’s Gilead Sciences GILD Stock Holding History

Sprott Inc’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-218,400	Closed	-$21.4M	–	158
2015 Q1	$21.4M	Buy	+218,400	New	+$22.2M	1.71%	15

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sprott Inc's GILD Position: Q4 2016 in Review

Sprott Inc sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 69,000 shares — an estimated $5.46M sold.

Sprott Inc first reported a position in GILD in Q4 2014 and held it in 6 quarters. The position peaked at $25.7M in Q1 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Sprott Inc reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Sprott Inc sold 69,000 Gilead Sciences shares in Q4 2016, an estimated $5.46M.
Sprott Inc first reported a position in Gilead Sciences in Q4 2014 and held it in 6 quarters.
Sprott Inc's Gilead Sciences position peaked at $25.7M in Q1 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Sprott Inc's 13F filing for Q4 2016, filed 27 Jan 2017.